Record each questionnaire as a dated result with the instrument, score, clinical interpretation, and the decision it informed. A score shows reported symptoms. The note still has to carry medical necessity, and the payer's current policy decides what else the claim needs.
Good documentation makes the record easier to review. It does not prove that treatment caused a score change or guarantee reimbursement. For the payer, setting, and state rules that decide what a note must contain, build the requirement map in the mental health documentation requirements guide. This page covers how to record outcome measures within that map.
Where questionnaire data fits
Measurement-based care (MBC) is the systematic use of standardized assessments to track reported symptoms over time. The data shows how questionnaire responses changed. Clinical review determines what that change means.
Trial evidence is group-level. A 2015 randomized trial enrolled 120 outpatients with moderate to severe major depression. Treatment decisions guided by guidelines and rating scales produced higher response and remission rates than clinician-choice care. That supports a measurement workflow. An individual score change still cannot establish why the change occurred.
Some coverage policies name rating scales directly. One Medicare contractor's transcranial magnetic stimulation LCD (L37086) asks for standardized rating scales to document a lack of improvement after psychotherapy. It allows retreatment to be considered when earlier treatment produced more than 50% improvement on a standard rating scale. Other payers, services, and jurisdictions set different requirements, so check the policy that applies.
Common assessment examples
Confirm that each form fits the population, purpose, workflow, and payer policy before adopting it.
PHQ-9 (Patient Health Questionnaire-9): nine items about the past two weeks, scored 0 to 27. Bands run from 0-4 (minimal) to 20-27 (severe). A score of 10 or higher is a common threshold for further assessment, not a diagnosis.
PHQ-2: the first two PHQ-9 items. A score of 3 or more is a positive screen that calls for the PHQ-9 or a clinical interview.
GAD-7 (Generalized Anxiety Disorder-7): seven items about the past two weeks, scored 0 to 21. Bands run from 0-4 (minimal) to 15-21 (severe). A score of 10 or higher is a common threshold for further assessment, not a diagnosis.
GAD-2: the first two GAD-7 items. A score of 3 or more is a positive screen that calls for the GAD-7 or a clinical interview.
CPT code 96127
CPT 96127 covers a brief emotional or behavioral assessment with scoring and documentation. It is reported per standardized instrument, as the descriptor quoted in the CY 2023 physician fee schedule final rule states. Payer rules vary on units per day, frequency, eligible instruments, supervision, and telehealth. Whether a service is billable also depends on medical necessity and on who performs each part of the work. Medicare's remote monitoring codes have separate device and data rules, covered in the remote monitoring guide.
A defensible assessment note usually records four elements:
- Instrument name: the specific measure, such as "PHQ-9", not "depression screening"
- Score: the numerical result, such as "Score: 15"
- Clinical interpretation: the symptom band and what the clinician concluded from the full assessment
- Action or plan: what you are doing based on the result
A complete documentation example:
> Administered PHQ-9 (patient self-completed). Score: 15, in the moderately severe symptom band, down from 20 on [date]. Reviewed item responses, functioning, safety, and the patient's account. Clinical assessment and plan documented separately. Reassessment timing follows the care plan.
Check the current Medicare, state Medicaid, or commercial payer policy that applies to the service before relying on a template.
What belongs in clinical notes
Beyond the 96127 elements, progress notes should show how the scores were used.
At treatment start: baseline scores with interpretation, presenting symptoms and severity, and treatment goals. If the plan names a score target, record its source and how it will be confirmed clinically.
At each visit: the current score and its comparison with baseline and the last comparable result. Add your interpretation, the decisions made from the full assessment, and the patient's account.
Periodically: progress toward goals, the recorded score change, functional changes in work, relationships, and daily activities, and the basis for continued treatment.
Tracking progress over time
Single scores are snapshots. Repeated scores show a trajectory, but no universal point change proves clinically meaningful improvement.
In a 2004 study of 434 older adults in the IMPACT trial, a five-point PHQ-9 difference was the estimated minimum clinically important change. That supports a review signal in a similar context, not a universal response rule. If your practice uses a change criterion, name its source in the note and confirm the interpretation against function, interview findings, and timing. The PHQ-9 tracking guide explains comparability and why response and remission labels need a protocol.
| Date | PHQ-9 | Recorded change | Notes |
|---|---|---|---|
| 01/15 | 18 | Baseline | Clinical context documented |
| 02/12 | 15 | Down 3 | Patient report reviewed |
| 03/12 | 11 | Down 4 | Function reviewed |
| 04/09 | 7 | Down 4 | Clinical assessment continues |
This table format is not required, but it lets a reviewer follow the record quickly.
Common documentation mistakes
Vague entries: "Depression screening administered" vs. "PHQ-9 administered, score 14, in the moderate symptom band. Interpretation and plan below."
Missing the clinical review: "PHQ-9 = 17, moderately severe depression" vs. "PHQ-9 = 17, in the moderately severe symptom band, up from 12. Reviewed item responses, functioning, safety, and the patient's account. The assessment and agreed plan are documented below."
Not connecting to medical necessity: "Continue weekly therapy" vs. "PHQ-9 remains 16 after 6 weeks. Interview findings and functional impairment continue to support weekly treatment. The score is one part of that assessment."
Overstating a score change: "PHQ-9 improved from 18 to 9, proving treatment worked" assigns a cause the questionnaire cannot establish. Write, "PHQ-9 total decreased from 18 to 9; the patient also reports better sleep and work attendance." Then document the clinician's interpretation.
Build it into the visit
Before the visit: send the questionnaire electronically so the patient can complete it at home or in the waiting room. The score is then ready when the session starts.
During the visit: review the result with the patient. For example: "Your PHQ-9 today is 12, down from 15 last time. Does that match how the past two weeks have felt?" The answer belongs in the note beside the score.
After the visit: a structured template makes the required elements harder to miss. If score interpretations are being copied forward unchanged, the template needs work.
Scheduling follow-up: match reassessment to the questionnaire's two-week recall period, the clinical context, and the care plan. Document the rationale for the interval you choose.
When scores are not improving
Not every patient responds to treatment. A clear record of what was observed and what changed serves the reviewer better than a vague note.
Document what you observed: "After 12 weeks of the documented treatment plan, PHQ-9 totals remain above 15. The patient reports persistent symptoms and functional limits."
Document your reasoning: "Reviewed the score pattern with the interview, functioning, adherence, adverse effects, and patient preferences. The clinical assessment and options discussed are recorded below."
Document ongoing medical necessity: "Continued symptoms require treatment modification and close follow-up. Weekly visits warranted during medication transition."
A record that shows assessment and adjustment over time is easier to defend than one that shows the same plan repeated without review.
Outcome data in payer contracts
Some contracts tie payment to quality reporting or outcome measures. Before offering data, check that it meets the contract's definitions for the cohort, measure, denominator, and missing results. A questionnaire total alone is not an outcome measure or proof of quality. The payer outcome data guide covers how to prepare that data.
Preparing for audits
If your claims are audited, outcome documentation supports the record. Reviewers may look for medical necessity, evidence that progress was monitored, the reasoning behind treatment plans, and consistency across the note.
Useful records include baseline and ongoing assessment scores, careful interpretation, the clinical basis for treatment decisions, and notes explaining why treatment continues. This supports review but does not guarantee audit or payment outcomes.
